Literature DB >> 2069139

Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.

C L Gonzalez1, L J Medeiros, E S Jaffe.   

Abstract

Nine patients had composite lymphoma in which Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL) involved the same anatomic site. Two of these patients had relapses of their tumors. In one, the initial biopsy specimen contained follicular and diffuse large cell NHL with unclassifiable HD, but the relapse showed diffuse large cell NHL with nodular sclerosis HD. In the other patient, both biopsy specimens showed follicular mixed NHL; the HD component in the initial biopsy specimen was nodular sclerosis, whereas, at relapse, it had the appearance of interfollicular HD. In the remaining seven patients, the HD component was subclassified as nodular sclerosis (three specimens) or mixed cellularity (three specimens), or it was unclassifiable (one specimen). The NHL component was categorized as diffuse large cell (two specimens), diffuse large cell immunoblastic (two specimens), follicular and diffuse large cell (one specimen), diffuse mixed small and large cell (one specimen), and lymphocytic lymphoma of intermediate differentiation (modified Rappaport classification) (one specimen). Paraffin section immunoperoxidase studies were done on the NHL component in eight patients (nine specimens) and on the HD component in six patients (seven specimens). In each of these, the NHL component was leukocyte common antigen (LCA) positive and Leu-M1 negative. In addition, the neoplastic cells were L26 positive and UCHL-1 negative, indicating a B-cell phenotype. In five of seven immunophenotyped cases, Reed-Sternberg (RS) and Hodgkin's (H) cells from the HD areas were Leu-M1 positive and LCA negative, reflecting an immunophenotype that is typical of non-lymphocyte-predominant HD. In two specimens, the malignant cells were negative for Leu-M1 and LCA (with positive internal controls). Composite lymphomas composed of HD and NHL are unusual, and cases of coexistent HD of the non-lymphocyte-predominant subtype and NHL are even less common. The results of the current study and a review of the literature indicate that this phenomenon usually involves a B-cell NHL that coexists with HD, perhaps further suggesting a close relationship between the malignant cells of HD (RS and H cells) and B lymphocytes.

Entities:  

Mesh:

Year:  1991        PMID: 2069139     DOI: 10.1093/ajcp/96.1.81

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  19 in total

1.  The bcl-2 gene translocation is undetectable in Hodgkin's disease by Southern blot hybridization and polymerase chain reaction.

Authors:  E Athan; A Chadburn; D M Knowles
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

2.  Composite follicular lymphoma and nodular lymphocyte predominance Hodgkin's disease.

Authors:  Jean-Louis Dargent; Laurence Lespagnard; Isabelle Meiers; Christophe Bradstreet; Pierre Heimann; Christiane De Wolf-Peeters
Journal:  Virchows Arch       Date:  2005-10-19       Impact factor: 4.064

3.  Transformation of follicular lymphoma to Epstein-Barr virus-related Hodgkin-like lymphoma.

Authors:  Madhu P Menon; Lloyd Hutchinson; Joanne Garver; Elaine S Jaffe; Bruce A Woda
Journal:  J Clin Oncol       Date:  2013-01-07       Impact factor: 44.544

4.  The bcl-2/JH gene rearrangement is undetectable in Hodgkin's lymphomas: results from the German Hodgkin trial.

Authors:  M Nolte; M Werner; W Spann; B Schnabel; R von Wasielewski; L Wilkens; K Hübner; R Fischer; A Georgii
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 5.  Relationship between Hodgkin's and non-Hodgkin's lymphomas.

Authors:  Rose-Marie Amini; Gunilla Enblad
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

Review 6.  The biology of human lymphoid malignancies revealed by gene expression profiling.

Authors:  Louis M Staudt; Sandeep Dave
Journal:  Adv Immunol       Date:  2005       Impact factor: 3.543

7.  Using biologic predictive factors to direct therapy of diffuse large B-cell lymphoma.

Authors:  Kieron Dunleavy; Cliona Grant; Wyndham H Wilson
Journal:  Ther Adv Hematol       Date:  2013-02

8.  Inconsistency of the immunophenotype of Reed-Sternberg cells in simultaneous and consecutive specimens from the same patients. A paraffin section evaluation in 56 patients.

Authors:  W S Chu; S L Abbondanzo; G Frizzera
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

9.  Nodular sclerosing Hodgkin's disease and large cell lymphoma. Immunophenotypic characterization of a composite case.

Authors:  M Paulli; R Rosso; S Kindl; E Boveri; M Sirchi; A De Medici; R Invernizzi; U Magrini
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

Review 10.  [Mediastinal lymphomas].

Authors:  S Rauthe; A Rosenwald
Journal:  Pathologe       Date:  2016-09       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.